-
公开(公告)号:PE20020522A1
公开(公告)日:2002-06-25
申请号:PE2001001021
申请日:2001-10-15
Applicant: ABBOTT LAB
Inventor: MA ZHENKUN , PHAN LY TAM , ZHANG SUOMING , DJURIC STEVAN , CLARK RICHARD F
IPC: A61K31/7048 , A61K31/7056 , A61P31/04 , C07H17/08
Abstract: SE REFIERE A DERIVADOS DE ERITROMICINA (CETOLIDOS 6-O-SUSTITUIDOS) DE FORMULA I DONDE A1 ES ARILO, HETEROARILO; Y1 ES ISOXAZOL, OXAZOL, ISOTIAZOL, DIHIDROISOXAZOL, DIHIDROOXAZOL; D1 ES HC-CH; C C; R1 ES H, Rp; Rp ES UN GRUPO PROTECTOR DE OH. TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION. LOS COMPUESTOS PUEDEN SER UTILES PARA EL TRATAMIENTO DE INFECCIONES BACTERIANAS SIN PRODUCIR EL EFECTO COLATERAL DE INTOLERANCIA INTESTINAL COMO NAUSEAS, VOMITOS
-
公开(公告)号:CA2420012A1
公开(公告)日:2002-04-25
申请号:CA2420012
申请日:2001-10-16
Applicant: ABBOTT LAB
Inventor: PHAM LY TAM , CLARK RICHARD F , MA ZHENKUN , DJURIC STEVAN , ZHANG SOUMING
IPC: A61K31/7056 , A61P31/04 , C07H17/08 , A61K31/7048
Abstract: Compounds having formula (I) are useful for treating bacterial infections while avoiding the concomitant liability of gastrointestinal intolerance. Compositions containing the compounds and methods of treatment using the compounds are also disclosed.
-
公开(公告)号:CZ20013223A3
公开(公告)日:2002-01-16
申请号:CZ20013223
申请日:2000-03-08
Applicant: ABBOTT LAB
Inventor: OR YAT SUN , CLARK RICHARD F , MA ZHENKUN , RUPP MICHAEL J
IPC: A61K31/7048 , A61P31/04 , C07H17/08
Abstract: The instant invention provides novel macrolide compounds and compositions useful in treating bacterial infections. Also provided are processes for preparing same. These macrolides are substituted on the 6-O-position with X'-Y'-Z', wherein X' is selected from the group consisting of C1-C10 alkyl, C3-C10 alkenyl, and C3-C10 alkynyl; Y' and Z' are independently selected from the group consisting of: (c) optionally substituted aryl, and (d) optionally substituted heteroaryl, with the proviso that both Y' and Z' are not both phenyl, and with the further proviso that Y' is not isoxazole when Z' is thiophenyl.
-
公开(公告)号:NO20014380L
公开(公告)日:2001-09-10
申请号:NO20014380
申请日:2001-09-10
Applicant: ABBOTT LAB
Inventor: OR YAT SUN , CLARK RICHARD F , MA ZHENKUN , RUPP MICHAEL J
IPC: A61K31/7048 , A61P31/04 , C07H17/08 , A61K31/70
Abstract: The instant invention provides novel macrolide compounds and compositions useful in treating bacterial infections. Also provided are processes for preparing same. These macrolides are substituted on the 6-O-position with X'-Y'-Z', wherein X' is selected from the group consisting of C1-C10 alkyl, C3-C10 alkenyl, and C3-C10 alkynyl; Y' and Z' are independently selected from the group consisting of: (c) optionally substituted aryl, and (d) optionally substituted heteroaryl, with the proviso that both Y' and Z' are not both phenyl, and with the further proviso that Y' is not isoxazole when Z' is thiophenyl.
-
公开(公告)号:NO20014380A
公开(公告)日:2001-09-10
申请号:NO20014380
申请日:2001-09-10
Applicant: ABBOTT LAB
Inventor: OR YAT SUN , CLARK RICHARD F , MA ZHENKUN , RUPP MICHAEL J
IPC: A61K31/7048 , A61P31/04 , C07H17/08 , A61K31/70
CPC classification number: C07H17/08
-
公开(公告)号:CA2398848A1
公开(公告)日:2001-08-30
申请号:CA2398848
申请日:2001-02-23
Applicant: ABBOTT LAB
Inventor: OR YAT SUN , YONG HONG , ZHANG SOUMING , MA ZHENKUN , NEMOTO PETER A
IPC: C07H17/08 , A61K31/335 , A61K31/7048 , A61P31/04
Abstract: Published without an
-
87.
公开(公告)号:AU737310B2
公开(公告)日:2001-08-16
申请号:AU9317698
申请日:1998-09-16
Applicant: ABBOTT LAB
Inventor: OR YAT SUN , MA ZHENKUN , CHU DANIEL T
IPC: A61K31/7042 , A61K31/7048 , A61K31/7052 , A61P31/04 , C07H17/00 , C07H17/08 , A61K31/70
Abstract: Novel 3'-N-modified 6-O-substituted erythromycin ketolide compounds and pharmaceutically acceptable salts and esters thereof having antibacterial activity having formula (I), (II), (III), (IV) or (V), compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically acceptable carrier, as well as a method for treating bacterial infections by administering to a mammal a pharmaceutical composition containing a therapeutically-effective amount of a compound of the invention.
-
公开(公告)号:NZ334274A
公开(公告)日:2001-02-23
申请号:NZ33427497
申请日:1997-09-02
Applicant: ABBOTT LAB
Inventor: OR YAT SUN , MA ZHENKUN , CLARK RICHARD F , CHU DANIEL T , PLATTNER JACOB J
IPC: A61K31/70 , A61K31/7048 , A61P31/04 , C07H17/00 , C07H17/08
Abstract: 6-Substituted ketolides of e.g. formula (II) or (III), and their salts, esters and prodrugs are new: Y + Z = X; X = OH, =NOR1 or =NOC(R5)(R6)OR1; or one of Y and Z = H; and the other = H, OH, protected OH or NR7R8; R1 = 1-12C alkyl (optionally substituted), 3-12C cycloalkyl or SiR2R3R4; R2-R4 = 1-12C alkyl or aryl; R5, R6 = H or 1-12C alkyl (optionally substituted), or R5 + R6 = 3-12C cycloalkyl; R7, R8 = H or 1-6C alkyl; or NR7R8 = 3-7 membered ring which, when the ring is 5-7 membered may optionally contain O, NH, N(1-6C alkyl), N(aryl), N(aryl-1-6C alkyl), N (substituted aryl-1-6C alkyl), N(heteroaryl), N(heteroaryl-1-6C alkyl), N(substituted heteroaryl-1-6C alkyl), S or S(O)n; n = 1 or 2; Ra = H or OH; Rc = H or hydroxy protecting group; R9 = 1-6C alkyl (optionally substituted), 3-7C cycloalkyl or optionally substituted aryl or heteroaryl; M = CONH, NHCO, NH, N=, NMe, NHCOO, NHCONH, OCONHY, OCOO, O, S(O)n, COO, OCO or CO; R = methyl (substituted by CN, F, CO2R10, S(O)nR10, NHCOR10, NHCONR11R12, aryl, substituted aryl, heteroaryl or substituted heteroaryl); 2-10C alkyl (optionally substituted), 3C alkenyl (substituted by halo, CHO, CO2R10, COR9, CONR11R12, CN, optionally substituted aryl or heteroaryl, 3-7C cycloalkyl or 1-12C alkyl substituted by heteroaryl); 4-10C alkenyl (optionally substituted), or 3-10C alkynyl optionally substituted); R10 = 1-3C alkyl (optionally aryl substituted), or heteroaryl substituted 1-3C alkyl; R11, R12 = H or 1-3C alkyl (optionally substituted); A, B, D, E = H, 1-6C alkyl (optionally substituted by optionally substituted), 3-7C cycloalkyl, optionally substituted aryl or heteroaryl, heterocycloalkyl or 1-6C alkyl substituted by MR9; provided that \- 2 of A, B, D and E = H; or any one pair of substituents, consisting of AB, AD, AE, BD, BE or DE taken with the atoms to which they are attached, form a 3- to 7-membered ring optionally containing O, NH, N(1-6C alkyl), N(aryl-1-6C alkyl), N(substituted aryl-1-6C alkyl), N(heteroaryl-1-6C alkyl), N(substituted heteroaryl-1-6C alkyl), S, S(O)n, CONH, CONR12, NHCO, NR12CO or C(=NH)NH.
-
89.
公开(公告)号:BG104340A
公开(公告)日:2001-01-31
申请号:BG10434000
申请日:2000-04-14
Applicant: ABBOTT LAB
Inventor: OR YAT S , MA ZHENKUN , CHU DANIEL T
IPC: A61K31/7042 , A61K31/7048 , A61K31/7052 , A61P31/04 , C07H17/00 , C07H17/08 , A61K31/70
Abstract: Novel 3'-N-modified 6-O substituted erythromycin ketolide compounds and pharmaceutically acceptable salts and esters thereof having antibacterial activity having formulae compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically acceptable carrier, as well as a method for treating bacterial infections by administering to a mammal a pharmaceutical composition containing a therapeutically-effective amount of a compound for the invention. 15 claims
-
公开(公告)号:NO20001439L
公开(公告)日:2000-05-29
申请号:NO20001439
申请日:2000-03-20
Applicant: ABBOTT LAB
Inventor: OR YAT SUN , MA ZHENKUN , CHU DANIEL T
IPC: A61K31/7042 , A61K31/7048 , A61K31/7052 , A61P31/04 , C07H17/00 , C07H17/08 , A61K31/70
Abstract: Novel 3'-N-modified 6-O-substituted erythromycin ketolide compounds and pharmaceutically acceptable salts and esters thereof having antibacterial activity having formula (I), (II), (III), (IV) or (V), compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically acceptable carrier, as well as a method for treating bacterial infections by administering to a mammal a pharmaceutical composition containing a therapeutically-effective amount of a compound of the invention.
-
-
-
-
-
-
-
-
-